Does the size of a ketogenic diet admission group influence outcomes?

Danayt Alem1, Leah Jager2, Zahava Turner3

  • 1School of Medicine, The Johns Hopkins University, Baltimore, MD, USA.

Insights

Admitting children with epilepsy in larger groups for ketogenic diet (KD) initiation is linked to longer treatment adherence. Larger groups, particularly of 3 children, showed increased KD duration, suggesting potential benefits of peer support.

Area of Science:

  • Pediatric Neurology
  • Dietary Therapies
  • Epilepsy Management

Background:

  • Pediatric centers commonly admit children for inpatient initiation of the ketogenic diet (KD) for epilepsy.
  • Group admissions are sometimes used to optimize staff resources and foster family support networks.
  • The impact of group admission size on ketogenic diet outcomes remains unclear.

Purpose of the Study:

  • To investigate the association between the size of inpatient admission groups and outcomes during ketogenic diet initiation for pediatric epilepsy.
  • To determine if group size influences the duration of the ketogenic diet or seizure reduction.

Main Methods:

  • Retrospective chart review of 245 children with intractable epilepsy undergoing KD initiation at Johns Hopkins Hospital (2010-2020).
  • Analysis of admission group sizes (1-5 children), 3-month seizure reduction, and total KD duration.
  • Linear mixed effects modeling was employed to assess the relationship between group size and KD duration.

Main Results:

  • Children admitted in groups of 3 showed significantly longer KD durations compared to those admitted alone (1.9 times longer, p=0.035).
  • Larger admission groups (3-5 children) were associated with 1.6 times longer KD durations than smaller groups (1-2 children, p=0.036).
  • No significant correlation was found between admission group size and 3-month seizure reduction.

Conclusions:

  • Initiating the ketogenic diet in larger inpatient groups, particularly groups of 3, is associated with longer treatment durations in children with epilepsy.
  • Potential factors contributing to longer adherence in larger groups may include enhanced peer and parent support.
  • Group admission size does not appear to impact short-term seizure reduction efficacy.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
62
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
39
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
105.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
217
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
43
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
163